[aaavl2821]

I wrote a blog about this earlier in the week. The focus is on the opportunity in biopharma generally but i touch on some of the key technologies of the last 15 years or so

Short answer: there is a "perfect storm" of innovation right now in bio. Tech from the 2000s genomic bubble is entering the mature phase of the hype cycle and ushering in a new era of potential curative therapy (gene therapy, cell therapy, personalized medicine). Avexis, a company treating a devastating neurological disease affecting infants using gene therapy, is ky favorite example to this

There is also the more widely hyped tech, AI, wearables, synthetic bio, etc, with massive potential, but these techs haven't had much impact on patients yet

Post here: http://newbio.tech/blog.html